8-K
filed September 6, 2023, 7:59 PM ET
ticker XAGE
CIK 0001842939
leadership
confidence high
sentiment neutral
materiality 0.65
Carmell announces CEO change, board restructuring, and post-merger savings focus on aesthetics
Longevity Health Holdings, Inc.
- CEO Randy Hubbell resigns effective Aug 31, 2023; Rajiv Shukla (Exec Chair) appointed Chairman & CEO.
- Four directors and four other execs depart as part of Axolotl Biologix integration; no disagreement cited.
- $8M milestone payment to Axolotl rescheduled to Aug 31, 2024; projected annual savings of ~$3M from terminations.
- Focus narrowed to aesthetics programs (skin rejuvenation, dental bone healing) with shorter path to commercialization.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Newlin resigned as Director at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James Hart resigned as Chief Medical Officer at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Chief Medical Officer
Exact text from the filing
As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Donna Godward resigned as Chief Quality Officer at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Chief Quality Officer
Exact text from the filing
As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Janet Vargo resigned as Vice President Clinical Services at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Vice President Clinical Services
Exact text from the filing
As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Randolph W. Hubbell resigned as Chief Executive Officer and President at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Chief Executive Officer and President
Exact text from the filing
As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steve Bariahtaris resigned as Director at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rajiv Shukla was appointed as Chief Executive Officer at Longevity Health Holdings, Inc..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
As of the Effective Date, Rajiv Shukla, the Company’s current Executive Chairman, has been appointed as the Chief Executive Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jaime Garza resigned as Director at Longevity Health Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.